Glycolytic Genes Predict Immune Status and Prognosis Non-Small-Cell Lung Cancer Patients with Radiotherapy and Chemotherapy

Figure 4

Construction of a risk model for NSCLC patients who have received chemotherapy or radiotherapy. (a) Lasso analysis, the analysis result with the smallest λ value, is selected. (b) Survival status: distribution of risk scores and heat map of candidate gene expression for patients in high-risk and low-risk groups. (c) Survival curves of the two groups of patients. (d) Time-dependent ROC curve of the risk model.

(a)

(b)

(c)

(d)

(e)